BRIACELL THERAPEUTICS CORP (BCTX) Stock Cash Flow
NASDAQ:BCTX - Nasdaq - CA1079301091 - Common Stock - Currency: USD
| TTM (2024-10-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.72M | -4.93M | -20.30M | -26.84M | -13.82M | |||
| Depreciation Amortization | 106.74K | 83.90K | 15.27K | 15.27K | 15.26K | |||
| Change In Working Capital | 4.77M | 7.05M | -3.53M | -391.29K | -2.28M | |||
| Other non cash items | -11.63M | -26.33M | 74.26K | 14.73M | 8.33M | |||
| OPERATING CASH FLOW | -23.48M | -24.13M | -23.74M | -12.48M | -7.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -456.80K | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | -225.00K | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | N/A | -681.80K | N/A | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -23.58K | -330.40K | |||
| Stock Issued/Repurchased | N/A | 4.42M | 3.95M | -3.66M | 65.33M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -57.12K | 0.00 | |||
| FINANCING CASH FLOW | N/A | 4.42M | 3.95M | -3.74M | 65.00M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -7.85M | -20.39M | -19.79M | -16.23M | 57.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -23.48M | -24.13M | -23.74M | -12.48M | -7.75M | |||
| Capital Expenditure | N/A | -456.80K | N/A | N/A | N/A | |||
| FREE CASH FLOW | -23.93M | -24.58M | -23.74M | -12.48M | -7.75M | |||
All data in USD